Practical Recommendation in Immuno & Molecular Oncology 8th Annual 2023
Format: 24 videos, size: 2.58 GB
Course Audience: oncologist
Overview:
Join us at the 8th Annual Practical Recommendations in Immuno and Molecular Oncology Meeting
PRIMO is a unique opportunity to receive CE credits while staying ahead of the latest advances in immuno and molecular oncology.
The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.
Target Audience
This activity has been designed to meet the educational needs of academic and community practitioners, as well as registered nurses, from all oncology specialties, treating all disease sites involved in the care of patients with cancer.
Learning Objectives
Practical considerations of applying biomarkers and targeted therapy Integration of immunotherapy, with a focus on novel management approaches Patient selection, as well as timing and sequencing of therapy Dealing with important trends, such as big data and defining value in cancer care
Feb 23 AML Where Are We Now and Where Are We Going (Video MP4 Format)
Feb 23 Current Status of CAR-T Therapy in Hematology (Video MP4 Format)
Feb 23 Integrative Oncology Treatment Approaches for Stress in Cancer Patients and Survivors (Video MP4 Format)
Feb 23 Novel Immunotherapy Approaches in Hepatobiliary Malignancies (Video MP4 Format)
Feb 23 Pancreatic Cancer Are We Finally Making Progress (Video MP4 Format)
Feb 23 Role of Immunotherapy in Myeloma (Video MP4 Format)
Feb 23 Update on Novel Therapies for NHL (Video MP4 Format)
Feb 23 Update on Therapy Options for Untreated and Relapsed CLL (Video MP4 Format)
Feb 24 Adjuvant and Neo-adjuvant Therapy for Lung Cancer (Video MP4 Format)
Feb 24 Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1) (Video MP4 Format)
Feb 24 Approach to NSCLC Without Targetable Mutations (Video MP4 Format)
Feb 24 Liquid Biopsy Advances in the Last Decade and Future Directions (Video MP4 Format)
Feb 24 Melanoma as a Paradigm for the Future of Immunotherapy (Video MP4 Format)
Feb 24 Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK) (Video MP4 Format)
Feb 24 Prostate Cancer Role of PSMA PET and Accurately Defining Neuroendocrine Prostate (Video MP4 Format)
Feb 24 Renal Cell Carcinoma (RCC) Current Approach to First Line Therapy and Beyond (Video MP4 Format)
Feb 24 Role of Immunotherapy in HNC (Video MP4 Format)
Feb 25 Antibody Drug Conjugates New Agents and Optimal Sequencing (Video MP4 Format)
Feb 25 Current Status of Cervical Cancer Screening (Video MP4 Format)
Feb 25 Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer (Video MP4 Format)
Feb 25 Endocrine Therapy for Advanced Breast Cancer Current and Future Strategies (Video MP4 Format)
Feb 25 Immunotherapy for Breast Cancer Updates and New Directions (Video MP4 Format)
Feb 25 Ovarian Cancer Beyond Carboplatin and Paclitaxel (Video MP4 Format)
Feb 25 Role of ADCs in Gynecological Malignancies (Video MP4 Format)